More research is needed to access genetic changes that may play a deleterious role in the clinical course of COVID-19 patients, including analysis of the ACE2 and APOE genes, major histocompatibility complex class I genes, Toll-like receptors, and others. This evidence concerns the gene ACE2 and COVID-19.